Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 19, 2010, Pages 8742-8747

  Kim, Byung Seok ^a   Kim, Il Kyu ^a   Park, Young Jun ^a   Kim, Yun Sun ^a   Kim, Yeon Jeong ^a   Chang, Woo Sung ^a   Lee, Yoon Sook ^a   Kweon, Mi Na ^b   Chung, Yeonseok ^c   Kang, Chang Yuil ^a,d  

^a Seoul National University   (South Korea)

^b International Vaccine Institute   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Seoul National University   (South Korea)

Author keywords

All trans retinoic acid; Immune tolerance; Immunotherapy; Plasticity; Rapamycin

Indexed keywords

IMMUNOGLOBULIN E; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RAPAMYCIN; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; EOSINOPHILIA; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; EOSINOPHILS; EPITOPES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; IMMUNOLOGIC MEMORY; INFLAMMATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 77952711172     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911756107     Document Type: Article

References (47)

1. Zhu J, Paul WE (2008) CD4 T cells: Fates, functions, and faults. Blood 112:1557-1569.
2. Wilson CB, Rowell E, Sekimata M (2009) Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9:91-105.
3. Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA (2006) T helper cell differentiation: Regulation by cis elements and epigenetics. Immunity 24:369-379.
4. Zhou L, Chong MM, Littman DR (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655.
5. Yang XO, et al. (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44-56.
6. Lee YK, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107.
7. Chung Y, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576-587.
8. Krawczyk CM, Shen H, Pearce EJ (2007) Functional plasticity in memory T helper cell responses. J Immunol 178:4080-4088. (Pubitemid 46492356)
9. Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202:1539-1547. (Pubitemid 41746600)
10. Brusko T, Bluestone J (2008) Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation. Eur J Immunol 38:931-934.
11. Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM (2008) Cutting edge: Antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol 181:8209-8213.
12. Riley JL, June CH, Blazar BR (2009) Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 30:656-665.
13. Miyara M, Wing K, Sakaguchi S (2009) Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol 123:749-755, quiz 756-757.
14. Chen W, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
15. Mucida D, Park Y, Cheroutre H (2009) From the diet to the nucleus: Vitamin A and TGF-beta join efforts at the mucosal interface of the intestine. Semin Immunol 21: 14-21.
16. Hill JA, et al. (2008) Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29:758-770.
17. Nolting J, et al. (2009) Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med 206:2131-2139.
18. Basu S, Golovina T, Mikheeva T, June CH, Riley JL (2008) Cutting edge: Foxp3- mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180:5794-5798.
19. Thorstenson KM, Khoruts A (2001) Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 167:188-195.
20. Moulton VR, Bushar ND, Leeser DB, Patke DS, Farber DL (2006) Divergent generation of heterogeneous memory CD4 T cells. J Immunol 177:869-876. (Pubitemid 44036587)
21. Wei J, et al. (2007) Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 104:18169-18174. (Pubitemid 350210839)
22. Chang JH, Kim YJ, Han SH, Kang CY (2009) IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: Potential role for ROS-mediated apoptosis. Eur J Immunol 39:1241-1251.
23. Haxhinasto S, Mathis D, Benoist C (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 205:565-574.
24. Sauer S, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 105:7797-7802. (Pubitemid 351872718)
25. Delgoffe GM, et al. (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30:832-844.
26. Gorelik L, Fields PE, Flavell RA (2000) Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165:4773-4777.
27. Veldhoen M, et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9:1341-1346.
28. Dardalhon V, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9: 1347-1355.
29. Saito K, et al. (2008) Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol 181:6889-6897.
30. Yamaguchi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27:145-159. (Pubitemid 47089022)
31. Kurashima K, et al. (2006) Asthma severity is associated with an increase in both blood CXCR3+ and CCR4+ T cells. Respirology 11:152-157. (Pubitemid 43356894)
32. Nakatani T, et al. (2001) CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 107:353-358. (Pubitemid 32173915)
33. Selvaraj RK, Geiger TL (2007) A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 178:7667-7677.
34. Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ (2004) CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173: 7259-7268.
35. Vukmanovic-Stejic M, et al. (2006) Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116:2423-2433.
36. Vukmanovic-Stejic M, et al. (2008) The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest 118:3639-3650.
37. Xiao S, et al. (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181:2277-2284.
38. Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4+ CD25+FoxP3+ regulatory T cells. Blood 105:4743-4748.
39. Turnquist HR, et al. (2007) Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 178:7018-7031.
40. Araki K, et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
41. Hegazy AN, et al. (2010) Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32:116-128.
42. Koch MA, et al. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10:595-602.
43. Zheng Y, et al. (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:351-356.
44. Chaudhry A, et al. (2009) CD4+ regulatory T cells control TH17 responses in a Stat3- dependent manner. Science 326:986-991.
45. Zhou X, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10:1000-1007.
46. Oldenhove G, et al. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31:772-786.
47. Kim JO, et al. (2004) Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J Allergy Clin Immunol 114:1332-1338.